title: Duration of antiplatelet or anticoagulant therapy after transcatheter aortic valve implantation in high risk patients; longer or shorter.
authors.affiliation: Gulhane Military Medical Academy, School of Medicine, Department of Cardiology, Etlik, Ankara, Turkey. Electronic address: drcengizozturk@yahoo.com.tr.
authors.forename: Cengiz
authors.initials: C
authors.lastname: Ozturk
authors.affiliation: Gulhane Military Medical Academy, School of Medicine, Department of Cardiology, Etlik, Ankara, Turkey.
authors.forename: Turgay
authors.initials: T
authors.lastname: Celik
authors.affiliation: Gulhane Military Medical Academy, School of Medicine, Department of Geriatric Medicine, Etlik, Ankara, Turkey.
authors.forename: Ahmet
authors.initials: A
authors.lastname: Ozturk
authors.affiliation: Gulhane Military Medical Academy, School of Medicine, Department of Cardiology, Etlik, Ankara, Turkey.
authors.forename: Sevket
authors.initials: S
authors.lastname: Balta
authors.affiliation: Gulhane Military Medical Academy, School of Medicine, Department of Cardiology, Etlik, Ankara, Turkey.
authors.forename: Atila
authors.initials: A
authors.lastname: Iyisoy
mesh_terms: D000925:Anticoagulants / Q000627:therapeutic use; D001021:Aortic Valve / Q000601:surgery; D001024:Aortic Valve Stenosis / Q000601:surgery; D006328:Cardiac Catheterization; D006350:Heart Valve Prosthesis; D019918:Heart Valve Prosthesis Implantation; D006801:Humans; D065467:Transcatheter Aortic Valve Replacement; D016896:Treatment Outcome
chemical_list: D000925:Anticoagulants
keywords: After transcatheter aortic valve implantation; Duration of antiplatelet therapy; High risk patients